Cargando…
Drug therapy for the prevention and treatment of bronchopulmonary dysplasia
Introduction: As more infants are surviving at younger gestational ages, bronchopulmonary dysplasia (BPD) remains as a frequent neonatal complication occurring after preterm birth. The multifactorial nature of the disease process makes BPD a challenging condition to treat. While multiple pharmacolog...
Autores principales: | Iyengar, Anjali, Davis, Jonathan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329808/ https://www.ncbi.nlm.nih.gov/pubmed/25762933 http://dx.doi.org/10.3389/fphar.2015.00012 |
Ejemplares similares
-
Pharmacoepidemiology of Drug Exposure in Intubated and Non-Intubated Preterm Infants With Severe Bronchopulmonary Dysplasia
por: Lewis, T., et al.
Publicado: (2021) -
Drug Therapy Trials for the Prevention of Bronchopulmonary Dysplasia: Current and Future Targets
por: Bhandari, Vineet
Publicado: (2014) -
Landscape analysis for a neonatal disease progression model of bronchopulmonary dysplasia: Leveraging clinical trial experience and real-world data
por: Barrett, Jeffrey S., et al.
Publicado: (2022) -
Deficiency of endothelial FGFR1 alleviates hyperoxia-induced bronchopulmonary dysplasia in neonatal mice
por: Long, Yanrong, et al.
Publicado: (2022) -
An Update on the Prevention and Management of Bronchopulmonary Dysplasia
por: Hennelly, Marissa, et al.
Publicado: (2021)